肌少症与慢性冠状动脉综合征共病机制及预后影响的研究进展

Research progress of sarcopenia and chronic coronary syndrome in comorbidity mechanisms and their impacts on prognosis

  • 摘要: 肌少症是一种以进行性、广泛性的骨骼肌量减少和/或功能下降为特征的老年综合征, 其发病率随着年龄的增长而逐年升高, 并且受到多种因素的共同影响, 包括遗传背景、生活方式、营养状态以及慢性疾病等。近年来的研究发现, 肌少症与慢性冠状动脉综合征(CCS)之间存在着显著的相关性, 不仅体现在发病频率上, 还涉及病情严重程度。此外, 肌少症与CCS之间存在共同的发病机制, 包括慢性炎症、氧化应激、细胞凋亡、胰岛素抵抗等多种病理生理过程。本文旨在综述当前关于肌少症与CCS共病关系的研究进展, 探讨其共同的病理生理基础以及对临床预后的影响。

     

    Abstract: Sarcopenia is an age-related syndrome characterized by progressive and widespread loss of skeletal muscle mass and/or decline in muscle function.Its incidence increases year by year with aging and is influenced by multiple factors, including genetic background, lifestyle, nutritional status, and chronic diseases.Recent studies have revealed a significant correlation between sarcopenia and chronic coronary syndromes (CCS), not only in terms of the frequency of occurrence but also the severity of the conditions.Moreover, sarcopenia and CCS share common pathogenic mechanisms, encompassing various pathophysiological processes such as chronic inflammation, oxidative stress, apoptosis, and insulin resistance.This article aimed to review the current research progress on comorbidity relationship between sarcopenia and CCS, explore their shared pathophysiological basis, and discuss their impacts on clinical prognosis.

     

/

返回文章
返回